Multiple intrathoracic thrombosis detected on ct scan in patient with antiphospholipid antibody syndrome: case report

Authors

Published 2023-12-19
Issue Vol. 14 No. 2 (2023): December 2023
Section Case Report
DOI: https://doi.org/10.30659/sainsmed.v14i2.1663
Keywords: Antiphospholipid Antibodi Syndrome, Deep Vein Trombosis

Abstract

Antiphospholipid antibody syndrome (APS) is the clinical correlation between antiphospholipid antibodies and hypercoagulability syndrome. The prevalence of APS in the general population is undetermined. APS disease carries a notable risk of vascular thrombosis. CT scan is the preferred imaging method for assessing thrombosis, although the timing of image acquisition should be considered. The case report detailed the discovery of many intrathoracic thromboses on a CT scan of a patient diagnosed with the uncommon condition APS. Case study: A 34-year-old woman was hospitalized due to dyspnea, cough, and a 3 kg weight loss over a three-month period. She has a background in Deep Vein Thrombosis (DVT). The test results showed abnormalities in protein C, protein S, and high D-dimer levels. The CT scan revealed numerous intrathoracic thrombi. Antiphospholipid syndrome (APS) is an immunological condition that elevates the likelihood of blood clot formation, resulting in thrombosis inside the arteries and veins. The approximate occurrence rate of APS is five occurrences per 100,000 individuals annually. Antiphospholipid syndrome (APS) leads to the formation of blood clots in the legs, a condition referred to as deep vein thrombosis (DVT). This patient had a history of deep vein thrombosis (DVT) and many blood clots within the chest cavity. A CT scan revealed persistent blood clots in the main pulmonary artery and the right and left pulmonary arteries. Antiphospholipid syndrome (APS) can lead to the formation of blood clots in both arteries and veins. CT scan is the preferred method for evaluating thrombosis, and numerous phases are required to examine all blood arteries.

Downloads

Download data is not yet available.

Author Biographies

  • Bekti Safarini, Sultan Agung Islamic University
    Radiology Department, Medical Faculty, Sultan Agung Islamic University Semarang, Indonesia
  • Dewi Intisari, Sultan Agung Islamic University
    Microbiology Department, Medical Faculty, Sultan Agung Islamic University Semarang, Indonesia

License

Creative Commons License

© 2023 Author(s). Published by Sains Medika: Jurnal Kedokteran dan Kesehatan. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Safarini, B., & Intisari, D. (2023). Multiple intrathoracic thrombosis detected on ct scan in patient with antiphospholipid antibody syndrome: case report. Sains Medika: Jurnal Kedokteran Dan Kesehatan, 14(2), 84-88. https://doi.org/10.30659/sainsmed.v14i2.1663

References

Chao, C., Adam, A., Kim, H., Min Htet, Z., Thawdar Oo, Z., Chen, D., Bachan, M., Khan, Z., & Vukelic, M. (2023). DVT Missed by ultrasound: Confirmed By CT Angiography in antiphospholipid syndrome but delayed. Chest, 164(4): A4068–A4069. https://doi.org/10.1016/j.chest.2023.07.2653

Chaturvedi, S., & R McCrae, K. (2017). Diagnosis and management of the antiphospholipid syndrome. Blood Reviews, 31 (6): 406–417. https://doi.org/10.1016/J.BLRE.2017.07.006

Da Silva, F. F., Levy, R. A., & De Carvalho, J. F. (2014). Cardiovascular Risk factors in the antiphospholipid syndrome. Journal of Immunology Research, 2014: 1–6. https://doi.org/10.1155/2014/621270

Dabit, J. Y., Valenzuela-Almada, M. O., Vallejo-Ramos, S., & Duarte-García, A. (2021). Epidemiology of antiphospholipid syndrome in the general population. Current Rheumatology Reports, 23(85): 1-9. https://doi.org/10.1007/s11926-021-01038-2

Garcia, D., Erkan, D. (2018). Diagnosis and management of the antiphospholipid syndrome. The New England Journal of Medicine, 378 (21): 2010–2021. https://doi.org/10.1056/NEJMra1705454

Dogan, H., De Roos, A., Geleijins, J., Huisman, M., & Kroft, L. (2015). The role of computed tomography in diagnosing acute and chronic pulmonary embolism. Diagnostic and Interventional Radiology, 21(4): 307–316. https://doi.org/10.5152/dir.2015.14403

El-Menyar, A., Nabir, S., Ahmed, N., Asim, M., Jabbour, G., & Al-Thani, H. (2016). Diagnostic implications of computed tomography pulmonary angiography in patients with pulmonary embolism. Annals of Thoracic Medicine, 11 (4): 269–276. https://doi.org/DOI: 10.4103/1817-1737.191868

Gomez-Puerta, J. A., & Cervera, R. (2014). Diagnosis and classification of the antiphospholipid syndrome. Journal of Autoimmunity. http://dx.doi.org/10.1016/j.jaut.2014.01.006

Green, D. (2022). Pathophysiology of Antiphospholipid Syndrome. Thrombosis and Haemostasis, 122(07): 1085–1095. https://doi.org/10.1055/a-1701-2809

Knight, J. S., Branch, D. W., & Ortel, T. L. (2023). Antiphospholipid syndrome: Advances in diagnosis, pathogenesis, and management. BMJ, e069717: 1-20. https://doi.org/10.1136/bmj-2021-069717

Lopes, M. R. U., Danowski, A., Funke, A., Rêgo, J., Levy, R., & Andrade, D. C. O. D. (2017). Update on antiphospholipid antibody syndrome. Revista Da Associação Médica Brasileira, 63(11): 994–999. https://doi.org/10.1590/1806-9282.63.11.994

Matyja-Bednarczyk, A., Swadzba, J., Iwaniec, T., Sanak, M., Dziedzina, S., Cmiel, A., & Musial, J. (2014). Risk factors for arterial thrombosis in an antiphospholipid syndrome. Thrombosis Research, 133: 173–176. http://dx.doi.org/10.1016/j.thromres.2013.22.012

Moore, A. J. E., Wachsmann, J., Chamarthy, M. R., Panjikaran, L., Tanabe, Y., & Rajiah, P. (2018). Imaging of acute pulmonary embolism: An update. Cardiovascular Diagnosis and Therapy, 8(3): 225–243. https://doi.org/10.21037/cdt.2017.12.01

Mora-Ramírez, M., González-Pacheco, H., & Amezcua-Guerra, L. (2016). Stents coated with mammalian target of rapamycin inhibitors (mTOR) appear to be the best choice in patients with antiphospholipid syndrome and myocardial infarction. JCR: Journal of Clinical Rheumatology, 22(5): p.281. https://doi.org/DOI: 10.1097/RHU.0000000000000409

Oliveira, D. C., Correia, A., & Oliveira, C. (2020). The issue of the antiphospholipid antibody syndrome. Journal of Clinical Medicine Research, 12(5): 286–292. https://doi.org/10.14740/jocmr4154

Saponjski, J., Stojanovich, L., Petrovic, J., & Saponsjki, D. (2017). The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome. Immunologic Research, 65: 482–486. https://doi.org/10.1007/s12026-016-8887-6

Schreiber, K., Sciascia, S., de Groot, P. G., Devreese, K., Jacobsen, S., Ruiz-Irastorza, G., Salmon, J. E., Shoenfeld, Y., Shovman, O., & Hunt, B. J. (2018). Antiphospholipid syndrome. Nature Reviews Disease Primers, 1: 1–20. https://doi.org/10.1038/nrdp.2017.103

Sciascia, S., Sanna, G., Murru, V., Roccatello, D., Khamashta, M. A., & Bertolaccini, M. L. (2015). The global antiphospholipid syndrome score in primary APS. Rheumatology, 54(1): 134–138. https://doi.org/10.1093/rheumatology/keu307

Sugiyama, K., Suzuki, S., Koizumi, N., & Ogino, H. (2020). Antiphospholipid syndrome with chronic thromboembolic pulmonary hypertension and coronary artery disease: A case report. Journal of Cardiothoracic Surgery, 15(225): 1-6. https://doi.org/10.1186/s13019-020-01254-4

Tzouvelekis, A. (2013). CT Findings of pulmonary involvement in antiphospholipid syndrome. British Journal of Medicine and Medical Research, 3(4): 855–867. https://doi.org/10.9734/BJMMR/2013/3007